Ultrasound-guided core needle biopsy of superficial lymph nodes
Authors:
- Gérôme BohelayGBGérôme Bohelay
- Maxime BattistellaMBMaxime Battistella
- Cécile PagèsCPCécile Pagès
- Constance de Margerie-MellonCMConstance de Margerie-Mellon
- Nicole Basset-SeguinNBNicole Basset-Seguin
- Manuelle ViguierMVManuelle Viguier
- Delphine KerobDKDelphine Kerob
- Nika MadjlessiNMNika Madjlessi
- Michel BaccardMBMichel Baccard
- Alain ArchimbaudAAAlain Archimbaud
- Christelle ComteCCChristelle Comte
- Samia MourahSMSamia Mourah
- 1 December 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 25 (6) , 519-527
Abstract
To investigate the diagnostic value of ultrasound-guided core needle biopsy (US-CNB) in suspected cases of lymph node metastasis from cutaneous melanoma. All patients with cutaneous melanoma followed in Saint-Louis Hospital between 2006 and 2010 who underwent US-CNB for suspicion of melanoma lymph node metastasis were reviewed retrospectively. Histopathological results of US-CNB samples were classified as melanoma, other malignancy, suspicious, inadequate, or benign. The diagnostic accuracy of US-CNB was assessed by comparison with two reference standards: histopathological examination of the radical lymph node dissection or, when this was not available, clinical and radiological follow-up. The data from 72 US-CNB were analyzed. Forty-four melanomas, 22 benign, three other malignancies, three inadequate samples, and no inconclusive specimens were diagnosed. Seventy-one US-CNB results were confirmed (98.6%). US-CNB achieved high sensitivity, specificity, and positive predictive value (respectively, 97.9, 100, and 100%). No adverse events were reported after the procedure. US-CNB provided a mean tissue volume of 16.7 mm per lymphadenopathy. US-CNB has diagnostic value similar to that of fine-needle aspiration cytology. It represents a reliable alternative method in melanoma lymph node metastasis to avoid surgery in patients who will not benefit from it. US-CNB provides relatively large samples of tissue suitable for comprehensive genomic analyses currently needed for research and personalized care of melanoma patients.Keywords
This publication has 35 references indexed in Scilit:
- Targeting Oncogenic Drivers and the Immune System in MelanomaJournal of Clinical Oncology, 2013
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAFThe Journal of Molecular Diagnostics, 2011
- Contemporary Diagnostic Imaging Modalities for the Staging and Surveillance of Melanoma Patients: a Meta-analysisJNCI: Journal of the National Cancer Institute, 2010
- Archival Fine-Needle Aspiration Cytopathology (FNAC) SamplesThe Journal of Molecular Diagnostics, 2010
- Effect of Advanced Imaging Technology on How Biopsies Are Done and Who Does ThemRadiology, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Cutaneous malignant melanoma in EuropeEuropean Journal of Cancer, 2004
- The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodesJournal of the American Academy of Dermatology, 1997